Efficacy of Hysteroscopic Bubble Test, Flow Test and Peristalsis Test.

Tubal Patency Clinical Trial

Official title:

Efficacy of Hysteroscopic Bubble Test, Flow Test, and Peristalsis Test.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04825041
• Other study ID #: 2021
• Status: Completed
• Start date: September 1, 2021
• Est. completion date: September 27, 2022

Study information

• Verified date: January 2024
• Source: Woman's Health University Hospital, Egypt
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Fallopian tube (FT) function is complex. One of the main functions is transport of sperms for fertilization and transport of the embry for implantation. Hysteroscopic access to "Darwish Hysteroscopic Triad" allows excellent way to assess FT patency. This study compares three ways of assessing FT patency separably or in combination: flow test, bubble flow test and peristalsis test. Combined bubble flow test and peristalsis test is recently published and coined (Darwishscope)1.

Description:

This study includes infertile women subjected to combined hysteroscopy and laparoscopy UGA. During hysteroscopy, on each side, three patency test are done successively: flow test, bubble flow test and peristalsis test. Gold standard diagnosis of tubal patency and status is concomitant laparoscopy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 155
• Est. completion date: September 27, 2022
• Est. primary completion date: September 22, 2022
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• infertile women

• Probably patent FT as proved by a previous hysterosalpingography or laparoscopy.

• Office setting.

• Postmenstrual

• Non use of hormones or hormonal contraceptives.

Exclusion Criteria:

Premenstrual period. Pathologic FT.

Related Conditions & MeSH terms

• Tubal Patency

Intervention

Diagnostic Test:
• Patency test
Successive flow test, bubble flow test and peristalsis test

Locations

Country	Name	City	State
Egypt	Woman's Health University Hospital	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
Woman's Health University Hospital, Egypt

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	FT patency	Success of each diagnostic test to assess FT patency.	6 months